This announcement is a separate document:
康臣葯業：(1) 建議採納2024年購股權計劃、(2) 建議修訂現有組織章程大綱及細則以及採納新組織章程大綱及細則及(3) 股東特別大會通告
CONSUN PHARMA: (1) PROPOSED ADOPTION OF 2024 SHARE OPTION SCHEME,(2) PROPOSED AMENDMENTS TO THE EXISTING MEMORANDUMAND ARTICLES OF ASSOCIATION AND ADOPTION OF THENEW MEMORANDUM AND ARTICLES OF ASSOCIATIONAND(3) NOTICE OF EGM
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.